Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지
DOI QR코드

DOI QR Code

COVID-19 and Cancer: Questions to Be Answered

  • Hong, Young Seon (Department of Medical Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea)
  • Received : 2021.02.02
  • Accepted : 2021.02.26
  • Published : 2021.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

The World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak to be a pandemic on March 12, 2020. In Korea, there have been 24,027 confirmed cases of COVID-19 and 420 deaths as of October 3, 2020. The clinical spectrum of COVID-19 ranges from asymptomatic infection to death. Cancer care in this pandemic has radically changed. The literature was reviewed. The COVID-19 pandemic has made it urgently necessary to profoundly re-organize cancer patients' care without compromising cancer outcomes. Several important questions in regard to COVID-19 infection in cancer patients have emerged. Are patients with cancer at a higher risk of COVID-19 infection? Are they at an increased risk of mortality and severe illness when infected with COVID-19? Does anticancer treatment affect the course of COVID-19? Based on the existing research, cancer patients with immunosuppression are vulnerable to COVID-19 infection, and cancer patients are more likely to experience severe COVID-19. However, chemotherapy and major surgery do not seem to be predictors of hospitalization or severe disease. Korean background data on patients with cancer and COVID-19 are lacking. Prospective multicenter studies on the outcomes of patients with cancer and COVID-19 should be conducted.

Keywords

References

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020;92:401-2. https://doi.org/10.1002/jmv.25678
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. https://doi.org/10.1056/NEJMoa2001017
  3. World Health Organization. Updated 2020 [Internet]. Geneva: World Health Organization; c2020 [cited 2020 Oct 3]. Available from: http://covid19.who.int.
  4. Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: Implication for infection prevention and control measures. J Korean Med Sci 2020;35:1-4. https://doi.org/10.3904/kjim.2019.317
  5. Korea Disease Control and Prevention Agency. Coronavirus disease-19 main website [Internet]. Osong; Korea Disease Control and Prevention Agency; c2020 [updated 2020; cited 2020 Oct 3]. Available from: http://ncov.mohw.go.kr/en.
  6. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020:323;1239-42. https://doi.org/10.1001/jama.2020.2648
  7. Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020 Apr;21:e180.
  8. Sung HK, Kim JY, Heo J, Seo H, Jang Y, Kim H, et al. Clinical course and outcomes of 3,060 patients with Coronavirus Disease 2019 in Korea, January-May 2020. J Korean Med Sci 2020;35:e280. https://doi.org/10.3346/jkms.2020.35.e280
  9. Moon SS, Lee K, Park J, Yun S, Lee YS, Lee DS. Clinical characteristics and mortality predictors of COVID-19 patients hospitalized at nationally-designated treatment hospitals. J Korean Med Sci 2020;35:e328. https://doi.org/10.3346/jkms.2020.35.e328
  10. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020;395:1907-18. https://doi.org/10.1016/s0140-6736(20)31187-9
  11. Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020;17:336. https://doi.org/10.1038/s41571-020-0366-2
  12. Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and Cancer: Lessons from a pooled meta-analysis. JCO Glob Oncol 2020;6:557-9.
  13. He W, Chen L, Yuan G, Fang Y, Chen W, Wu D, et al. COVID-19 in persons with hematological cancers. Leukemia 2020;34:1637-45. https://doi.org/10.1038/s41375-020-0836-7
  14. Ma J, Yin J, Qian Y, Wu Y. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study. J Infect 2020;81:318-56.
  15. Ogimi C, Englund JA, Bradford MC, Qin X, Boeckh M, Waghmare A. Characteristics and outcomes of coronavirus infection in children: The role of viral factors and an immunocompromised state. J Pediatric Infect Dis Soc 2019;8:21-8. https://doi.org/10.1093/jpids/pix093
  16. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol 2020;31:894-901. https://doi.org/10.1016/j.annonc.2020.03.296
  17. Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, et al. Determinants of COVID-19 disease severity in patients with cancer. Nature Med 2020;26:1218-23. https://doi.org/10.1038/s41591-020-0979-0
  18. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020;323:1775-6.
  19. Liang W, Guam W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-7. https://doi.org/10.1016/s1470-2045(20)30096-6
  20. Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nat Rev Clin Oncol 2020;17:329-31. https://doi.org/10.1038/s41571-020-0370-6
  21. Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med 2020;26:1218-23. https://doi.org/10.1038/s41591-020-0979-0